Aperio Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$3.02M Sell
116,226
-7,262
-6% -$188K 0.01% 1052
2020
Q3
$1.22M Buy
123,488
+1,140
+0.9% +$11.3K ﹤0.01% 1347
2020
Q2
$422K Buy
122,348
+19,173
+19% +$66.1K ﹤0.01% 1853
2020
Q1
$316K Buy
103,175
+7,681
+8% +$23.5K ﹤0.01% 1875
2019
Q4
$491K Buy
95,494
+8,538
+10% +$43.9K ﹤0.01% 1806
2019
Q3
$449K Buy
86,956
+10,710
+14% +$55.3K ﹤0.01% 1815
2019
Q2
$461K Buy
76,246
+12,844
+20% +$77.7K ﹤0.01% 1822
2019
Q1
$458K Buy
63,402
+15,140
+31% +$109K ﹤0.01% 1797
2018
Q4
$357K Sell
48,262
-460
-0.9% -$3.4K ﹤0.01% 1869
2018
Q3
$264K Sell
48,722
-1,015
-2% -$5.5K ﹤0.01% 2073
2018
Q2
$177K Sell
49,737
-383
-0.8% -$1.36K ﹤0.01% 2181
2018
Q1
$103K Buy
50,120
+21,775
+77% +$44.7K ﹤0.01% 2214
2017
Q4
$75K Sell
28,345
-14,051
-33% -$37.2K ﹤0.01% 2218
2017
Q3
$223K Buy
42,396
+21,766
+106% +$114K ﹤0.01% 2076
2017
Q2
$73K Sell
20,630
-1,851
-8% -$6.55K ﹤0.01% 2191
2017
Q1
$116K Buy
22,481
+9,117
+68% +$47K ﹤0.01% 2101
2016
Q4
$51K Sell
13,364
-14,108
-51% -$53.8K ﹤0.01% 2104
2016
Q3
$246K Buy
27,472
+171
+0.6% +$1.53K ﹤0.01% 1825
2016
Q2
$192K Buy
27,301
+1,826
+7% +$12.8K ﹤0.01% 1873
2016
Q1
$217K Sell
25,475
-1,275
-5% -$10.9K ﹤0.01% 1836
2015
Q4
$351K Buy
26,750
+2,489
+10% +$32.7K ﹤0.01% 1524
2015
Q3
$89K Buy
24,261
+11,454
+89% +$42K ﹤0.01% 1869
2015
Q2
$74K Hold
12,807
﹤0.01% 1968
2015
Q1
$75K Buy
12,807
+138
+1% +$808 ﹤0.01% 1929
2014
Q4
$99K Hold
12,669
﹤0.01% 1834
2014
Q3
$62K Sell
12,669
-885
-7% -$4.33K ﹤0.01% 1713
2014
Q2
$84K Buy
13,554
+731
+6% +$4.53K ﹤0.01% 1691
2014
Q1
$69K Buy
+12,823
New +$69K ﹤0.01% 1991
2013
Q4
Sell
-12,081
Closed -$67K 1940
2013
Q3
$67K Buy
+12,081
New +$67K ﹤0.01% 1759